BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
4.205
+0.005 (0.12%)
Apr 25, 2025, 4:00 PM EDT - Market closed
BioAge Labs Employees
As of December 31, 2024, BioAge Labs had 64 total employees, including 62 full-time and 2 part-time employees. The number of employees increased by 8 or 14.29% compared to the previous year.
Employees
64
Change (1Y)
8
Growth (1Y)
14.29%
Revenue / Employee
n/a
Profits / Employee
-$1,111,078
Market Cap
151.65M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 64 | 8 | 14.29% |
| Dec 31, 2023 | 56 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BIOA News
- 5 weeks ago - BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024 - GlobeNewsWire
- 6 weeks ago - Final Deadline for the BioAge Labs, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - BIOA - PRNewsWire
- 6 weeks ago - BIOA Deadline Today: BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit - PRNewsWire
- 7 weeks ago - BioAge Labs (BIOA) Abandons Obesity Drug Amid Shareholder Lawsuit – Hagens Berman - GlobeNewsWire
- 7 weeks ago - BioAge Labs (BIOA) Shares Plummet After Discontinuing Trial Just 2 Months After IPO - Hagens Berman - Accesswire
- 7 weeks ago - BIOA Deadline: BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit - PRNewsWire
- 7 weeks ago - BioAge Labs (BIOA) Shares Plummet After Discontinuing Trial Just 2 Months After IPO– Hagens Berman - GlobeNewsWire
- 2 months ago - BIOA REMINDER: BioAge Labs was Sued for Securities Violations; Investors are Alerted to Contact BFA Law before March 10 Deadline (NASDAQ:BIOA) - GlobeNewsWire